[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]

about

[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]

Item

http://www.wikidata.org/entity/Q74630527

description

im Februar 1999 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 February 1999

@en

wetenschappelijk artikel

@nl

name

[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]

@en

[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]

@nl

type

Item

label

[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]

@en

[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]

@nl

prefLabel

[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]

@en

[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]

@nl

P1476

[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]

@en

P2093

Bystedt T

http://www.w3.org/2001/XMLSchema#string

P304

888-892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Suad Efendic

Claes-Göran Östenson

P577

1999-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13200841

http://www.w3.org/2001/XMLSchema#string

P698

10089733

http://www.w3.org/2001/XMLSchema#string

P921

Serine peptidase inhibitor Kazal type 4

type-2 diabetes